Respiratory - Breathlessness and wheeze Flashcards
patient with breathlessness , wheeze and cough and a new onset rash after exposure to hairdye
what is the most likely diagnosis
a.asthma
b.copd
c.bronchiectasis
d.left ventricular failure
e.anyphylaxis
e.anyphylaxis
patient with wheeze, cough, breathlessness with angina, prev MI patient also has oedema
what is the most likely diagnosis
a.asthma
b.copd
c.bronchiectasis
d.left ventricular failure
e.anyphylaxis
d.left ventricular failure
what is the most common cause of wheeze, cough and breathlessness
copd
hyperinflation and flattened diaphragm on cxr is indicative of what
a.asthma
b.copd
c.bronchiectasis
d.left ventricular failure
b.copd
if FEV1:FVC ratio is <0.7 what is indicated
obstructive disorder
a ………….. in a1 antitrypsin causes neutrophil elastase to go unnopposed and the alveoli are destroyed
a.deficiency
b.overproduction
a.deficiency
FEV 1 >= 80% predicted
GOLD 1
FEV 1 50-79 % predicted
GOLD 2
FEV 1 30-49 % predicted
GOLD3
FEV 1 <30 % predicted
GOLD4
COUGH AND SPUTUM for more than ……….. months is required to diagnose bronchitus
3 minths
emphysema pathophysiology
destruction of alveolar walls
what is the first step in management of copd
a.SABA as needed
b.LABA/LAMA
c.LABA/LAMA/ICS
d.stop smoking
d.stop smoking
what is the second stage of copd management
a.SABA as needed
b.LABA/LAMA
c.LABA/LAMA/ICS
d.stop smoking
a.SABA as needed
what is the third stage of copd management
a.SABA as needed
b.LABA/LAMA
c.LABA/LAMA/ICS
d.stop smoking
b.LABA/LAMA
what is the next step in copd management after LABA/LAMA if it still affects day to day quality of life or they have 1+ exacerbation per year
a.SABA as needed
b.LABA/LAMA
c.LABA/LAMA/ICS
d.stop smoking
c.LABA/LAMA/ICS
as a trial for 3 months
if no improvement
back to LABA/LAMA maintainence
asthma
patients present younger
variable symptoms
asthma pathophysiology
inhaled allergen
immune response
airway inflammation
TH2 response
eosinophils
bronchospasm
remodelling and airway oedema
reversibility of ….% or more or 200ml is supportive of asthma diagnosis
a.5%
b.25%
c.12%
d.10%
c.12%
what is the first treatment for asthma
a.SABA
b. SABA + ICS
c. SABA+ ICS+ LABA
d.SABA + ICS (increased dose) +LABA
e.SABA +ICS (increased dose)
a.SABA
what is the 2nd step for asthma treatment
a.SABA
b. SABA + ICS
c. SABA+ ICS+ LABA
d.SABA + ICS (increased dose) +LABA
e.SABA +ICS (increased dose)
b. SABA + ICS
what is the 3rd step in asthma management
a.SABA
b. SABA + ICS
c. SABA+ ICS+ LABA
d.SABA + ICS (increased dose) +LABA
e.SABA +ICS (increased dose)
c. SABA+ ICS+ LABA
patient on SABA,ICS and LABA for asthma . beneffiting from the addition of the LABA but still uncontrolled what should be offered next
a.SABA
b. SABA + ICS
c. SABA+ ICS+ LABA
d.SABA + ICS (increased dose) +LABA
e.SABA +ICS (increased dose)
d.SABA + ICS (increased dose) +LABA
patient on SABA,ICS and LABA for asthma . no response from the addition of the LABA , still uncontrolled what should be offered next
a.SABA
b. SABA + ICS
c. SABA+ ICS+ LABA
d.SABA + ICS (increased dose) +LABA
e.SABA +ICS (increased dose)
e.SABA +ICS (increased dose)
if patient on SABA, LABA and highest doses of ICS and still persistent poor control of asthma what should be offered
SABA, LABA , high dose ICS, and leukotriene receptor antagonist
then oral steroid tablets and specialist referral